PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec-1-ene | 212-819-2 | 872-05-9 | - | - | 3 | - | - | - | - | - | - | Details |
Dec-1-ene, dimers, hydrogenated | 500-228-5 | 68649-11-6 | - | - | 4 | - | - | - | - | - | - | Details |
Dec-1-ene, homopolymer, hydrogenated Dec-1-ene, oligomers, hydrogenated | 500-183-1 | 68037-01-4 | - | - | 3 | - | - | - | - | - | - | Details |
Dec-1-ene, trimers, hydrogenated | 500-393-3 | 157707-86-3 | - | - | 4 | - | - | - | - | - | - | Details |
Decan-1-ol | 203-956-9 | 112-30-1 | 1 | - | 1 | - | - | 1 | - | - | - | Details |
Decan-4-olide | 211-892-8 | 706-14-9 | - | - | 2 | - | - | - | - | - | - | Details |
Decan-5-olide | 211-889-1 | 705-86-2 | - | - | 1 | - | - | - | - | - | - | Details |
Decanal | 203-957-4 | 112-31-2 | - | - | 2 | - | - | - | - | - | - | Details |
Decane | 204-686-4 | 124-18-5 | - | - | 2 | - | - | - | - | - | - | Details |
Decanoic acid | 206-376-4 | 334-48-5 | - | - | - | - | - | 1 | - | - | - | Details |
Decanol, branched and linear | 291-169-1 | 90342-32-8 | - | - | 1 | - | - | - | - | - | - | Details |
Decene | 246-870-7 | 25339-53-1 | - | - | 3 | - | - | - | - | - | - | Details |
Decene, hydroformylation products, high boiling | 935-454-7 | - | - | - | 2 | - | - | - | - | - | - | Details |
Decene, hydroformylation products, low boiling | 938-875-4 | - | - | - | 1 | - | - | - | - | - | - | Details |
Desmedipham | 237-198-5 | 13684-56-5 | - | - | - | - | - | 1 | - | - | - | Details |
Di(benzothiazol-2-yl) disulphide | 204-424-9 | 120-78-5 | - | - | 2 | - | - | - | - | - | - | Details |
Di(tetraethylammonium)hexahydroxoplatinate(IV) | 848-537-7 | 1912392-88-1 | - | - | 1 | - | - | - | - | - | - | Details |
Di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide | 229-782-3 | 6731-36-8 | 1 | 1 | 6 | - | - | - | - | - | - | Details |
Di-tert-butyl trisulphide | 224-226-6 | 4253-90-1 | - | - | 5 | - | - | - | - | - | - | Details |
Di-tert-dodecyl disulphide | 248-468-7 | 27458-90-8 | - | - | 1 | - | - | - | - | - | - | Details |
di-µ-oxo-bis-[(tetra-2-ethylhexanoate)molybdenum] | 700-831-5 | - | - | - | 1 | - | - | - | - | - | - | Details |
Diallyl 2,2'-oxydiethyl dicarbonate | 205-528-7 | 142-22-3 | - | - | 1 | - | - | - | - | - | - | Details |
Diallyldimethylammonium chloride | 230-993-8 | 7398-69-8 | - | - | 2 | - | - | - | - | - | - | Details |
dialuminium iron tetraoxide, spinel type | 931-286-3 | - | - | - | 1 | - | - | - | - | - | - | Details |
dialuminium manganese tetraoxide, spinel type | 927-806-3 | 1302-69-8 | - | - | 2 | - | - | - | - | - | - | Details |